Track the Biomed-Lublin Wytwórnia Surowic I Szczepionek SA stock price and the full management transaction log of the company, a listed equity based in Poland. Shares trade on the PL market, under the authority of KNF. Operating in the Health Care sector, Biomed-Lublin Wytwórnia Surowic I Szczepionek SA has published 8 public disclosures. The latest transaction was disclosed on 18 May 2026 (Notification PDMR). All data is openly available.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Biomed-Lublin Wytwórnia Surowic I Szczepionek SA is a Polish company specializing in the production of serums and vaccines. It operates in the healthcare and pharmaceutical sector.